Challenges in Revascularization in Patients With Systemic Lupus Erythematosus
Rodrigo Uriel Palacios1, Sebastián Garibaldi1, Efraín Sebastián Castillo Mendoza1
1Intensive Coronary Care Unit, Sanatorio Sagrado Corazón, Buenos Aires, Argentina.
Systemic lupus erythematosus (SLE) with antiphospholipid syndrome (APS) can cause acute myocardial infarction. Prompt treatment involving reperfusion, immunosuppression, and anticoagulation is crucial for recovery in these complex cardiovascular cases.
Area of Science:
- Cardiology
- Rheumatology
- Immunology
Background:
- Systemic lupus erythematosus (SLE) significantly elevates cardiovascular risk via inflammation and thrombophilia.
- Antiphospholipid syndrome (APS) can further exacerbate cardiovascular complications in SLE patients.
More Related Videos
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
05:25Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease IV: Nursing Management
Atherosclerosis III: Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
